We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.31%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$16.4B
AUM Growth
+$49.9M
(+0.3%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
43.8%
Holding
1,532
New
77
Increased
144
Reduced
521
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coty
COTY
|
+$139M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$38M |
| 3 |
GCP
GCP Applied Technologies Inc.
GCP
|
+$34.7M |
| 4 |
Sonida Senior Living
SNDA
|
+$25.5M |
| 5 |
Theravance Biopharma
TBPH
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$68M |
| 2 |
ConocoPhillips
COP
|
+$44.3M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$35.7M |
| 4 |
Zimmer Biomet
ZBH
|
+$33.7M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.47% |
| 2 | Healthcare | 12.64% |
| 3 | Industrials | 9.32% |
| 4 | Technology | 8.7% |
| 5 | Consumer Staples | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Primis Financial Corp
FRST
$382M
| $4.13M | 0.03% |
252,772
-40,700
| -14% | -$582K |
|
|
BRS
252
DELISTED
Bristow Group, Inc.
BRS
| $4.08M | 0.02% |
199,261
-7,140
| -3% | -$108K |
|
|
TXNM
253
TXNM Energy Inc
TXNM
$6.47B
| $4.05M | 0.02% |
118,100
| – | – |
|
254
CSX Corp
CSX
$98.6B
| $4.01M | 0.02% |
335,187
-10,200
| -3% | -$114K |
|
255
Home Depot
HD
$332B
| $4M | 0.02% |
29,843
+275
| +0.9% | +$35.4K |
|
256
Globe Life
GL
$13.5B
| $3.98M | 0.02% |
53,900
| – | – |
|
257
NN Inc
NNBR
$272M
| $3.97M | 0.02% |
208,650
-950
| -0.5% | -$16.8K |
|
|
PX
258
DELISTED
Praxair Inc
PX
| $3.95M | 0.02% |
33,678
+3,585
| +12% | +$426K |
|
259
Unitil
UTL
$1,000M
| $3.94M | 0.02% |
86,969
-3,235
| -4% | -$135K |
|
|
PPBI
260
DELISTED
Pacific Premier Bancorp
PPBI
| $3.83M | 0.02% |
108,469
| – | – |
|
261
Chemung Financial Corp
CHMG
$390M
| $3.81M | 0.02% |
104,725
-360
| -0.3% | -$11.4K |
|
262
HSBC
HSBC
$355B
| $3.77M | 0.02% |
103,961
-3,321
| -3% | -$118K |
|
263
Vanguard S&P 500 ETF
VOO
$968B
| $3.75M | 0.02% |
18,250
-600
| -3% | -$120K |
|
264
First Horizon
FHN
$12.1B
| $3.71M | 0.02% |
185,334
-6,194
| -3% | -$109K |
|
265
Meta Platforms (Facebook)
META
$1.51T
| $3.66M | 0.02% |
31,792
+2,051
| +7% | +$252K |
|
266
Ameriprise Financial
AMP
$46.8B
| $3.6M | 0.02% |
32,474
-201
| -0.6% | -$21.2K |
|
267
Northrop Grumman
NOC
$77B
| $3.56M | 0.02% |
15,295
-900
| -6% | -$209K |
|
268
Navient
NAVI
$774M
| $3.53M | 0.02% |
215,103
-100,000
| -32% | -$1.55M |
|
269
Liberty Media Series A
FWONA
$22.3B
| $3.5M | 0.02% |
116,469
-783
| -0.7% | -$22.4K |
|
|
ANCX
270
DELISTED
Access National Corp
ANCX
| $3.48M | 0.02% |
125,267
| – | – |
|
271
Bristol-Myers Squibb
BMY
$127B
| $3.46M | 0.02% |
59,193
+941
| +2% | +$51.4K |
|
272
LCI Industries
LCII
$2.51B
| $3.42M | 0.02% |
31,735
-42,925
| -57% | -$4.27M |
|
|
BCR
273
DELISTED
CR Bard Inc.
BCR
| $3.4M | 0.02% |
15,134
| – | – |
|
|
TFCFA
274
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $3.35M | 0.02% |
119,466
-3,641
| -3% | -$98K |
|
275
Union Pacific
UNP
$182B
| $3.3M | 0.02% |
31,818
-835
| -3% | -$82.1K |
|
Similar funds
SAM
First Manhattan's Q4 2016 Portfolio in Review
As of Q4 2016, First Manhattan held 1,532 positions worth $16.4B, up 0.3% from $16.4B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
First Manhattan's Q4 2016 filing shows 77 new, 144 increased, 521 reduced and 96 closed positions. Its largest new stake was Coty: 6,723,666 shares worth $123M. The largest sale was Allergan plc, an estimated $68M.
By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q4 2016 buy was Coty: 6,723,666 shares worth $123M.
- First Manhattan added most to Teva Pharmaceuticals in Q4 2016, an estimated $38M increase.
- First Manhattan's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $68M.
- First Manhattan fully exited Starz - Series A in Q4 2016, selling an estimated $2.9M.
- First Manhattan's ten largest holdings make up 44% of its $16.4B portfolio in Q4 2016.
- First Manhattan opened 77 new positions and closed 96 in Q4 2016.
- First Manhattan's portfolio value rose 0.3% quarter-over-quarter to $16.4B.
Based on First Manhattan's 13F filing for Q4 2016, filed 25 Jan 2017.